Insider Transactions in Q1 2024 at Natera, Inc. (NTRA)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 29
2024
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,235
-3.36%
|
$210,275
$65.09 P/Share
|
|
Jan 29
2024
|
Steven Leonard Chapman CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
14,813
-5.66%
|
$962,845
$65.09 P/Share
|
|
Jan 29
2024
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
4,265
-2.05%
|
$277,225
$65.09 P/Share
|
|
Jan 29
2024
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct |
546
-0.11%
|
$35,490
$65.09 P/Share
|
|
Jan 29
2024
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Open market or private sale
|
Direct |
3,426
-1.73%
|
$222,690
$65.09 P/Share
|
|
Jan 29
2024
|
John Fesko PRESIDENT, CHIEF BUS. OFFICER |
SELL
Open market or private sale
|
Direct |
2,358
-2.13%
|
$153,270
$65.09 P/Share
|
|
Jan 26
2024
|
Matthew Rabinowitz EXECUTIVE CHAIRMAN |
BUY
Grant, award, or other acquisition
|
Direct |
68,976
+6.04%
|
-
|
|
Jan 26
2024
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
31,352
+24.59%
|
-
|
|
Jan 26
2024
|
Steven Leonard Chapman CEO AND PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct |
86,220
+24.78%
|
-
|
|
Jan 26
2024
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
27,433
+11.63%
|
-
|
|
Jan 26
2024
|
Jonathan Sheena |
BUY
Grant, award, or other acquisition
|
Direct |
9,405
+1.93%
|
-
|
|
Jan 26
2024
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
BUY
Grant, award, or other acquisition
|
Direct |
31,352
+13.65%
|
-
|
|
Jan 26
2024
|
John Fesko PRESIDENT, CHIEF BUS. OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
31,352
+22.05%
|
-
|
|
Jan 26
2024
|
Roy D. Baynes |
BUY
Grant, award, or other acquisition
|
Direct |
215
+1.7%
|
$13,545
$63.79 P/Share
|
|
Jan 26
2024
|
Roelof Botha |
BUY
Grant, award, or other acquisition
|
Direct |
352
+50.0%
|
$22,176
$63.79 P/Share
|
|
Jan 26
2024
|
James Healy |
BUY
Grant, award, or other acquisition
|
Direct |
264
+0.62%
|
$16,632
$63.79 P/Share
|
|
Jan 26
2024
|
Herm Rosenman |
BUY
Grant, award, or other acquisition
|
Direct |
303
+0.49%
|
$19,089
$63.79 P/Share
|
|
Jan 24
2024
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
944
-1.44%
|
$63,248
$67.0 P/Share
|
|
Jan 23
2024
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,202
-1.63%
|
$145,332
$66.25 P/Share
|
|
Jan 22
2024
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
771
-1.12%
|
$52,428
$68.16 P/Share
|
|
Jan 22
2024
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,250
+1.79%
|
-
|
|
Jan 22
2024
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
892
-0.49%
|
$60,656
$68.16 P/Share
|
|
Jan 22
2024
|
Steven Leonard Chapman CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
1,958
-1.1%
|
$133,144
$68.16 P/Share
|
|
Jan 22
2024
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct |
351
-0.04%
|
$23,868
$68.16 P/Share
|
|
Jan 21
2024
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,145
+1.67%
|
-
|
|
Jan 21
2024
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
644
+0.35%
|
-
|
|
Jan 21
2024
|
Steven Leonard Chapman CEO AND PRESIDENT |
BUY
Exercise of conversion of derivative security
|
Direct |
1,774
+0.99%
|
-
|
|
Jan 21
2024
|
Jonathan Sheena |
BUY
Exercise of conversion of derivative security
|
Direct |
143
+0.03%
|
-
|
|
Jan 20
2024
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,522
+2.24%
|
-
|
|
Jan 20
2024
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
856
+0.47%
|
-
|
|
Jan 20
2024
|
Steven Leonard Chapman CEO AND PRESIDENT |
BUY
Exercise of conversion of derivative security
|
Direct |
3,386
+1.89%
|
-
|
|
Jan 20
2024
|
Jonathan Sheena |
BUY
Exercise of conversion of derivative security
|
Direct |
191
+0.04%
|
-
|
|
Jan 03
2024
|
Jonathan Sheena |
SELL
Open market or private sale
|
Indirect |
1,000
-1.54%
|
$60,000
$60.59 P/Share
|
|
Jan 03
2024
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct |
5,000
-0.53%
|
$300,000
$60.32 P/Share
|